Blood Reviews
Volume 22, Issue 4 , Pages 173-186, July 2008

Thrombocytopenia in the Neonate

  • Irene Roberts

      Affiliations

    • Professor of Paediatric Haematology and Honorary Consultant Paediatric Haematologist, Imperial College, London
    • Corresponding Author InformationCorresponding author. Tel.: +44 208 383 2163; fax: +44 208 742 9335.
  • ,
  • Simon Stanworth

      Affiliations

    • Consultant Haematologist, National Blood Service and Honorary Consultant Paediatric Haematologist, Oxford Radcliffe Hospitals, Oxford, UK
  • ,
  • Neil A Murray

      Affiliations

    • Senior Clinical Research Associate National Blood Service, Oxford, John Radcliffe Hospital, Headington, Oxford, UK

published online 24 April 2008.

Summary 

Thrombocytopenia is one of the commonest haematological problems in neonates, affecting at least 25% of all admissions to neonatal intensive care units (NICUs) [Murray NA, Howarth LJ, McCloy MP et al. Platelet transfusion in the management of severe thrombocytopenia in neonatal intensive care unit patients. Transfus Med 2002;12:35–41; Garcia MG, Duenas E, Sola MC et al. Epidemiologic and outcome studies of patients who received platelet transfusions in the neonatal intensive care unit. J Perinatol 2001;21:415–20; Del Vecchio A, Sola MC, Theriaque DW et al. Platelet transfusions in the neonatal intensive care unit: factors predicting which patients will require multiple transfusions. Transfusion 2001;41:803–8]. Although a long list of disorders associated with neonatal thrombocytopenia can be found in many textbooks, newer classifications based on the timing of onset of thrombocytopenia (early vs. late) are more useful for planning diagnostic investigations and day-to-day management. The mainstay of treatment of neonatal thrombocytopenia remains platelet transfusion although it is important to note that no studies have yet shown clinical benefit of platelet transfusion in this setting. Indeed some reports even suggest that there may be significant adverse effects of platelet transfusion in neonates, including increased mortality, and that the effects of transfusion may differ in different groups of neonates with similar degrees of thrombocytopenia [Bonifacio L, Petrova A, Nanjundaswamy S, Mehta R. Thrombocytopenia related neonatal outcome in preterms. Indian J Pediatr 2007;74:269–74; Kenton AB, Hegemier S, Smith EO et al. Platelet transfusions in infants with necrotizing enterocolitis do not lower mortality but may increase morbidity. J Perinatol 2005;25:173–7]. There is also considerable variation in transfusion practice between different countries and between different neonatal units. Here we review recent progress in understanding the prevalence, causes and pathogenesis of thrombocytopenia in the newborn, the clinical consequences of thrombocytopenia and developments in neonatal platelet transfusion.

Keywords: Thrombocytopenia, Neonates, Platelet transfusion, Neonatal alloimmune thrombocytopenia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0268-960X(08)00023-4

doi:10.1016/j.blre.2008.03.004

Blood Reviews
Volume 22, Issue 4 , Pages 173-186, July 2008